Saturday - October 10, 2026

Category Archives: Science

Myelodysplastic Syndrome Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 120+ Leading Players Wheeling the Therapeutics Landscape

The Myelodysplastic Syndrome clinical trial analysis report delivers important insights into ongoing research on 120+ pipeline Myelodysplastic Syndrome Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 08, 2026, DelveInsight’s “Myelodysplastic Syndrome Pipeline Insights 2026” report provides … Continue reading →

Portable Ultrasound Bladder Scanner Market to Grow from USD 278.13 Million at a CAGR of 3.80% Through 2032Portable Ultrasound Bladder Scanner Market

(Albany, New York) – October 08, 2026 – DelveInsight’s “Portable Ultrasound Bladder Scanner Market” report offers an in-depth understanding of the global portable ultrasound bladder scanner industry, covering market size, segmentation trends, regional dynamics, and competitive landscape through 2032. To know … Continue reading →

Acute Coronary Syndrome Market is Projected to Reach USD 9 Billion by 2036 Owing to Rising Disease Incidence and Advancements in Targeted Cardiovascular Therapies | DelveInsight

The market dynamics for Acute Coronary Syndrome (ACS) are witnessing significant growth driven by the rising incidence of acute myocardial infarction, an aging population, increasing prevalence of cardiovascular risk factors, and continued advances in antithrombotic, lipid-lowering, and anti-inflammatory therapies. (Albany, … Continue reading →

Diabetic Macular Edema Market is Projected to Grow by 2036 Owing to Rising Diabetes Burden and Advancements in Long-Acting Retinal Therapies | DelveInsight

The market dynamics for Diabetic Macular Edema are witnessing steady growth driven by the increasing prevalence of diabetes, growing disease burden, improvements in retinal screening and diagnosis, continued dominance of anti-VEGF therapies, and increasing adoption of long-acting and sustained-delivery treatments. … Continue reading →

Dravet Syndrome Market is Projected to Grow by 2036 Owing to Rising Diagnosis and Advancements in Gene-Targeted Therapies | DelveInsight

The market dynamics for Dravet syndrome are witnessing steady growth, driven by increasing disease awareness, improvements in genetic testing and diagnosis, growing adoption of targeted anti-seizure therapies, and continued investment in precision and disease-modifying approaches. The therapeutic landscape is gradually … Continue reading →

Duchenne Muscular Dystrophy Market is Projected to Grow at an 11% CAGR by 2036 Owing to the Advancement of Gene Therapies and Disease-Modifying Treatments | DelveInsight

The market dynamics for Duchenne Muscular Dystrophy (DMD) are witnessing significant growth driven by increasing genetic screening and diagnosis, advancements in exon-skipping and gene-replacement therapies, a strong clinical development pipeline, growing regulatory support for rare-disease therapies, and increasing healthcare investment. … Continue reading →